BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30307119)

  • 1. Clinical Proteomics for Post-Hematopoeitic Stem Cell Transplantation Outcomes.
    Paczesny S; Metzger J
    Proteomics Clin Appl; 2019 Mar; 13(2):e1800145. PubMed ID: 30307119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of graft-versus-host disease biomarkers.
    Paczesny S
    Blood; 2013 Jan; 121(4):585-94. PubMed ID: 23165480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease biomarkers: omics and personalized medicine.
    Paczesny S; Raiker N; Brooks S; Mumaw C
    Int J Hematol; 2013 Sep; 98(3):275-92. PubMed ID: 23959582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.
    Presland RB
    Expert Rev Proteomics; 2017 Nov; 14(11):997-1006. PubMed ID: 28974115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants.
    Iacobescu M; Pop C; Uifălean A; Mogoşan C; Cenariu D; Zdrenghea M; Tănase A; Bergthorsson JT; Greiff V; Cenariu M; Iuga CA; Tomuleasa C; Tătaru D
    Front Immunol; 2024; 15():1327035. PubMed ID: 38433830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
    Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
    Front Immunol; 2019; 10():295. PubMed ID: 30891031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for posttransplantation outcomes.
    Paczesny S
    Blood; 2018 May; 131(20):2193-2204. PubMed ID: 29622549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.
    Paczesny S
    Br J Haematol; 2021 Mar; 192(6):951-967. PubMed ID: 32039480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for Allogeneic HCT Outcomes.
    Adom D; Rowan C; Adeniyan T; Yang J; Paczesny S
    Front Immunol; 2020; 11():673. PubMed ID: 32373125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trials of Graft versus Host Disease prophylaxis in haemopoietic stem cell transplantation.
    Potter V; Moore J
    Rev Recent Clin Trials; 2008 May; 3(2):130-8. PubMed ID: 18474024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics for hematopoietic stem cell transplantation.
    Weissinger EM; Basílio-Queirós D; Metzger J; Bieling LM; Ganser A
    Expert Rev Proteomics; 2020 Mar; 17(3):201-206. PubMed ID: 32228239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma biomarkers in graft-versus-host disease: a new era?
    Paczesny S; Levine JE; Braun TM; Ferrara JL
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):33-8. PubMed ID: 19147075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
    Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
    Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.